This list is an analysis based on recent market events. It's not an investment recommendation.
About
Saluda Medical, Inc., a medical device company, develops treatments for chronic neurological conditions in the United States, Australia, Europe, and internationally. The company offers a closed-loop, dose-control platform which senses and measures neural responses to stimulation and automatically adjusts therapy based on real-time neurophysiological feedback. It provides Evoke, an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain, and is designed to treat chronic neuropathic pain by providing spinal cord stimulation (SCS) therapy that senses and measures neural activation to optimize therapy and reduce patient and clinician burden. The company was founded in 2011 and is based in Bloomington, Minnesota.
The current price of SLD.AU is A$0.25 AUD — it has increased by +2.04% in the past 24 hours. Watch Saluda Medical stock price performance more closely on the chart.
What is Saluda Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Saluda Medical stocks are traded under the ticker SLD.AU.
In which sector is Saluda Medical located?▼
Saluda Medical operates in the Other sector.
When did Saluda Medical complete a stock split?▼
Saluda Medical has not had any recent stock splits.
Where is Saluda Medical headquartered?▼
Saluda Medical is headquartered in Bloomington, Australia.